You can buy or sell SGMO and other stocks, options, ETFs, and crypto commission-free!
Sangamo Therapeutics, Inc. engages in researching and developing transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. Read More The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
52 Week High
52 Week Low
-$0.34 per share
-$0.24 per share